News by Subject Medicine & Health

Men with high-risk prostate cancer with at least one additional aggressive feature have the best outcomes when treated with multiple healthcare disciplines, known as multimodality care, according to a UCLA study.

This review highlights the genesis of ROS within cells by various routes and their role in cancer therapies.

Black men most likely to benefit from advanced prostate cancer therapies are 11% less likely to get them than non-Black men.

Researchers report that about a quarter of localized prostate cancers may demonstrate immunologic traits that would allow a substantial number of patients with prostate cancer to benefit from immunotherapies.

Final results from a study of a blood test that can detect more than 50 types of cancer have shown that it is accurate enough to be rolled out as a multi-cancer screening test among people at higher risk of the disease, including patients aged 50 years or older, without symptoms. In a paper published in the leading cancer journal Annals of Oncology, researchers report that the test accurately detected cancer, often before any symptoms arose, while having a very low false positive rate.

Abdominal obesity appears to be associated with a greater risk of developing aggressive prostate cancer. This link was demonstrated in a study led by Professor Marie-Élise Parent of Institut national de la recherche scientifique (INRS) and published in the journal Cancer Causes & Control.